RE: RE: RE: Robert McInnisSchiff,
Pharmagap is not a US bank, therefore the comparison is moot.
CEO should be held accountable for Share price depreciation, as much as they are praised for share price appreciation. Even though his best friend is also his paycheck, Bob has to act in the best interest of the company, and its (OVERALL) shareholders. Not just BRYDEN. I know I, along with so many others, are frustrated by the current share price, I would like to know what MCINNIS has to say for this. I have sent emails to the company, and the only replies I have had back were from
I would like to see an update. As a shareholder I want to know what is happening behind the scenes.
My opinion of Bryden selling his shares, I dont think he needs the money anymore. I think he was just lining up the ducks, incase the funding from FED Gov't didn't come through on his precious Plasco Project. Now we know he got the money, he isn't in a hurry to sell.
I know eventually we will be rewarded for our patients, but I am still waiting for some answers and Schiff doesn't know any of them!